aTyr Pharma, Inc.ATYRNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank31
3Y CAGR-10.1%
5Y CAGR-37.8%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-10.1%/yr
vs -29.3%/yr prior
5Y CAGR
-37.8%/yr
Recent acceleration
Acceleration
+19.1pp
Accelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 6.98% |
| 2024 | 8.51% |
| 2023 | 41.25% |
| 2022 | 9.60% |
| 2021 | 0.00% |
| 2020 | 74.82% |
| 2019 | 56.42% |
| 2018 | 38.34% |
| 2017 | 23.51% |
| 2016 | 19.38% |